explore -WSS

explore

author：Wikipedia 2025-09-30 08:50:19 - browse：394

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

Biotech startup ReNAgade Therapeutics is cutting staff just seven months after raising the largest Series A round in the industry this year.

ReNAgade launched in May with hopes of becoming a one-stop shop for medicines targeting RNA, the genetic blueprints that cells use to make proteins instrumental in numerous diseases. These types of medicines are in high demand following the advent of mRNA vaccines for Covid and RNA-silencing therapies made by companies like Alnylam Pharmaceuticals.

ReNAgade was able to capitalize on that excitement when it raised a $300 million Series A round led by MPM Capital’s BioImpact Capital and F2 Ventures. But in recent days, the company decided to lay off around 10% of its 100-person team, according to a company statement and former employees’ posts on social media.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Amazon on where the company's health care bets are headed next

leisure time

WSS

Making AI in medicine accessible to smaller, and rural hospitals

'Make People Better': The CRISPR babies story you probably don't know

Crinetics acromegaly drug succeeds in late

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

Medicare says breakthrough device reimbursement rule to come by summer

Dairy farmers resist CDC push for PPE against bird flu virus

explore

explore

knowledge

In age of alternative facts, a scholarly course on calling out crap

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

DIEP, the 'gold standard' of breast reconstruction, is under threat

First recipient of genetically engineered pig kidney has died

Guidelines to prevent youth baseball injuries need more muscle

The 10 drugs up first for Medicare price negotiation

23andMe had bad news about my health. I wish a person had delivered it

Stem cell treatment guidelines are released by FDA

Medical leaders decry Supreme Court decision on affirmative action

Covid hospitalizations on the rise, Humana says

focus

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

AstraZeneca chief proposes a novel edit to the drug pricing bill

A new House health package & hospitals’ new site

Advances in CAR

NIH nominee Bertagnolli will get October confirmation hearing

How to fix cancer clinical trials' diversity problem

leisure time

explore

Wikipedia

hotspot